CHICAGO — The addition of immunotherapy to radiation therapy and surgery significantly extended DFS for certain patients with soft tissue sarcoma, according to results of a randomized phase 2 trial.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.